Compare Amylx Pharmaceuticals Inc (AMLX) vs Allbirds Inc (BIRD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Allbirds Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Allbirds Inc trades at $2.59 (market cap $30.00M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 88× Allbirds Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Allbirds Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | BIRD | |
|---|---|---|
Market Cap | $2.64B | $30.00M |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $16.99 |
52-Week Low | $7.82 | $2.21 |
Enterprise Value | $2.39B | $48.86M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Allbirds Inc
Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →
